Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial Cancer

Table 1

Clinicopathological characteristics and urinary sFas levels and VEGF expressions of the UC patients.

Variables		Urinary sFas (ng/mL)	value
		M ± IQR
Gender			0.312
Male	51	177.3 ± 94.2
Female	31	158.0 ± 68.8
Age (years)			0.741
60	62	168.1 ± 72.0
60	20	162.5 ± 86.0
Grade			0.039
LGPUC	42	157.0 ± 78.3
HGPUC	40	179.6 ± 91.2
T stage			0.000
NMIBC	56	139.0 ± 71.3
MIBC	26	230.5 ± 113.2
VEGF expression			0.000
Negative	21	92.5 ± 41.3
Positive	61	194.0 ± 99.5

NMIBC: nonmuscle invasive bladder cancer; MIBC: muscle invasive bladder cancer; LGPUC: low grade papillary urothelial cancer; HGPUC: high grade papillary urothelial cancer.